Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure

BACKGROUND: Candida glabrata is the third leading cause of candidaemia in Turkey; however, the data regarding antifungal resistance mechanisms and genotypic diversity in association with their clinical implication are limited. OBJECTIVES: To assess genotypic diversity, antifungal susceptibility and...

Descripción completa

Detalles Bibliográficos
Autores principales: Arastehfar, Amir, Daneshnia, Farnaz, Salehi, Mohammadreza, Yaşar, Melike, Hoşbul, Tuğrul, Ilkit, Macit, Pan, Weihua, Hagen, Ferry, Arslan, Nazlı, Türk‐Dağı, Hatice, Hilmioğlu‐Polat, Süleyha, Perlin, David S., Lass‐Flörl, Cornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497236/
https://www.ncbi.nlm.nih.gov/pubmed/32413170
http://dx.doi.org/10.1111/myc.13104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497236/
https://www.ncbi.nlm.nih.gov/pubmed/32413170
http://dx.doi.org/10.1111/myc.13104

Ejemplares similares